Home > Insider Trading > Filing (0001237899-14-000076)

Filing Details

Accession Number:: 0001237899-14-000076
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-19 16:41:49
Reporting Period:: 2014-11-17

Filing Date:: 2014-11-19
Accepted Time:: 2014-11-19 16:41:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1391382	J Robert Terifay	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Commercial	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-11-17	48,750	$21.25	68,779	No	4	M	Direct
Common Stock	Disposition	2014-11-17	2,578	$401.75	66,201	No	4	F	Direct
Common Stock	Disposition	2014-11-17	23,810	$401.75	42,391	No	4	F	Direct
Common Stock	Disposition	2014-11-18	62	$400.45	42,329	No	4	S	Direct
Common Stock	Disposition	2014-11-18	400	$401.42	41,929	No	4	S	Direct
Common Stock	Disposition	2014-11-18	1,500	$402.71	40,429	No	4	S	Direct
Common Stock	Disposition	2014-11-18	2,150	$403.86	38,279	No	4	S	Direct
Common Stock	Disposition	2014-11-18	3,252	$404.75	35,027	No	4	S	Direct
Common Stock	Disposition	2014-11-18	7,278	$405.85	27,749	No	4	S	Direct
Common Stock	Disposition	2014-11-18	3,720	$406.89	24,029	No	4	S	Direct
Common Stock	Disposition	2014-11-18	2,200	$407.85	21,829	No	4	S	Direct
Common Stock	Disposition	2014-11-18	1,800	$408.62	20,029	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-11-17	48,750	$0.00	48,750	$21.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-12-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,620	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 400 shares of Company stock on November 18, 2014 at prices ranging from $401.11 to $401.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 18, 2014 at prices ranging from $402.29 to $403.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,150 shares of Company stock on November 18, 2014 at prices ranging from $403.32 to $404.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,252 shares of Company stock on November 18, 2014 at prices ranging from $404.35 to $405.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 7,278 shares of Company stock on November 18, 2014 at prices ranging from $405.35 to $406.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,720 shares of Company stock on November 18, 2014 at prices ranging from $406.38 to $407.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,200 shares of Company stock on November 18, 2014 at prices ranging from $407.38 to $408.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,800 shares of Company stock on November 18, 2014 at prices ranging from $408.47 to $408.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012.